Rethinking Drug Discovery
Sygnature scientists discuss and share their thoughts about drug discovery, laboratory practice and how to beat some of the world’s worst illnesses.
We have also launched our own webinar series, check it out.
Sygnature scientists discuss and share their thoughts about drug discovery, laboratory practice and how to beat some of the world’s worst illnesses.
We have also launched our own webinar series, check it out.
17th February 2025
Sygnature Discovery boosts growth of its In…
12th February 2025
Sygnature Discovery Appoints New Chief Commercial Officer…
23rd January 2025
Sygnature Discovery appoints Rick Davies to spearhead…
9th October 2024
Sygnature Discovery has Chosen Elsevier as New…